TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 234 filers reported holding TG THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $368 | -8.9% | 44,010 | +170.6% | 0.03% | -12.5% |
| Q2 2023 | $404 | -2.2% | 16,266 | -40.7% | 0.03% | +6.7% |
| Q1 2023 | $413 | -11.4% | 27,428 | -30.4% | 0.03% | -23.1% |
| Q4 2022 | $466 | -99.9% | 39,393 | -25.9% | 0.04% | +34.5% |
| Q3 2022 | $315,000 | +5.7% | 53,150 | -24.2% | 0.03% | +7.4% |
| Q2 2022 | $298,000 | +2.8% | 70,105 | +130.0% | 0.03% | +200.0% |
| Q1 2022 | $290,000 | +45.7% | 30,483 | +191.3% | 0.01% | +28.6% |
| Q4 2021 | $199,000 | – | 10,466 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |